Since 2009, we have been developing processes and gaining unparalleled experience with live biotherapeutic products (LBPs), so that today Arranta Bio is delivering on its vision to be the leading, best-in-class microbiome contract development and manufacturing organization (CDMO).
Arranta is more than a CDMO; we are a strategic partner, teaming up with innovators, aligning ourselves with their vision to unlock the potential of the microbiome, and bringing their therapies from lab to market. We support early clinical supply through to commercial manufacturing with an unparalleled commitment to build and operate the capacity needed to support this sector.
Whether you are just starting out or encountering challenges unlocking the potential of your product, Arranta has the scientific expertise to bring your LBP products to life.
Arranta is your partner for every step of the journey, whether your company is new to the sector, been a pioneer for some time, or a large biopharma company with an interest in the potential of the microbiome to improve healthcare.
Our capacity has been built specifically for LBP Manufacturing…and it’s available now.
We understand it’s about more than just having capacity. Our team members are Arranta’s greatest strength.
Quality is at the center of everything we do.
years of expertise
sq feet of facilities
Our actALIVE™ Fast-to-Clinic Program delivers high-yielding, high-viability LBPs for clinical trial use in an accelerated timeline based on Arranta’s ALIVE Biotherapeutic Products™ manufacturing platform. It leverages 12+ years of research and development, know-how, and expertise with aerobic, anaerobic, and spore-forming organisms, and has already supported over 20 LBP products’ entry into the clinic.
Immediate release & recovery
Viable, high activity
Efficient, scalable process
There has never been a greater acceleration in scientific understanding of gut microbiota and the linkage to diseases that exist today. Arranta Bio is proud to serve pioneering innovators on this exciting healthcare frontier.Learn More
We’re always open to engaging with people interested in our company or the microbiome therapy sector in general.
We look forward to hearing from you.